Orchard Therapeutics plc (ORTX)

Orchard Therapeutics Revenue

Orchard Therapeutics had revenue of $6.30M in the quarter ending September 30, 2023, with 9.09% growth. This brings the company's revenue in the last twelve months to $21.84M, up 35.21% year-over-year. In the year 2022, Orchard Therapeutics had annual revenue of $22.66M with 1,252.54% growth.

• Revenue (ttm): $21.84M
• Revenue Growth: +35.21%
• P/S Ratio: n/a
• Revenue / Employee: $131,560
• Employees: 166
• Market Cap: n/a

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2022	22.66M	20.98M	1,252.54%
Dec 31, 2021	1.68M	-920.00K	-35.45%
Dec 31, 2020	2.60M	82.00K	3.26%
Dec 31, 2019	2.51M	437.00K	21.05%
Dec 31, 2018	2.08M	-	-